Product Information
DULOXETINE HCL DR 30 MG CAP is a generic product labeled by BluePoint Laboratories, priced at $0.1008 per EA under NDC 68001059504. Its NADAC has been published 117 times since Apr 3, 2024.
Strength
30 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001059504
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DULOXETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208706On Market Since
7/28/2023
Pharmacological Classes
Price Statistics
The NADAC for DULOXETINE HCL DR 30 MG CAP has been published 117 times since Apr 3, 2024, and over the history we have for it it has risen 14.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1008 per EA |
|---|---|
| All-time high | $0.1008 (Jun 24, 2026) |
| All-time low | $0.0696 (May 22, 2024) |
| 52-week high | $0.1008 |
| 52-week low | $0.0773 |
| Median price | $0.0784 |
| Average price | $0.0798 |
| Largest weekly change | -19.4% (Apr 17, 2024) |
| Weeks tracked | 117 |
| Tracking since | Apr 3, 2024 |
Generic Alternatives
The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 22% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DULOXETINE HCL DR 30 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DULOXETINE HCL DR 30 MG CAP, manufactured by BluePoint Laboratories, is $0.1008 per EA (NDC 68001059504), effective Jun 24, 2026.
How has the price of DULOXETINE HCL DR 30 MG CAP changed over time?
Over the history we have for it, the NADAC for DULOXETINE HCL DR 30 MG CAP has risen 14.5%. It has been tracked across 117 weekly CMS publications since Apr 3, 2024.
What are the highest and lowest recorded NADAC prices for DULOXETINE HCL DR 30 MG CAP?
Since Apr 3, 2024, the NADAC for DULOXETINE HCL DR 30 MG CAP has ranged from a low of $0.0696 (May 22, 2024) to a high of $0.1008 (Jun 24, 2026), with a median of $0.0784 per EA.
Are there cheaper alternatives to DULOXETINE HCL DR 30 MG CAP?
Yes. 9 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, DULOXETINE HCL DR 30 MG CAP, is $0.0782 per EA — about 22% below DULOXETINE HCL DR 30 MG CAP.
Who manufactures DULOXETINE HCL DR 30 MG CAP?
DULOXETINE HCL DR 30 MG CAP (NDC 68001059504) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.
Related Drugs
Same classification